These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37938506)

  • 21. Combined subcutaneous implantable cardioverter defibrillator and pacemaker devices in complex congenital heart disease: a single-center experienced based study.
    Sarubbi B; Ciriello GD; Papaccioli G; Correra A; Romeo E; Grimaldi N; Colonna D; Palma M
    J Interv Card Electrophysiol; 2023 Oct; ():. PubMed ID: 37878161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-in-Human Chronic Implant Experience of the Substernal Extravascular Implantable Cardioverter-Defibrillator.
    Crozier I; Haqqani H; Kotschet E; Shaw D; Prabhu A; Roubos N; Alison J; Melton I; Denman R; Lin T; Almeida A; Portway B; Sawchuk R; Thompson A; Sherfesee L; Liang S; Lentz L; DeGroot P; Cheng A; O'Donnell D
    JACC Clin Electrophysiol; 2020 Nov; 6(12):1525-1536. PubMed ID: 33213813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
    Weinstock J; Bader YH; Maron MS; Rowin EJ; Link MS
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
    Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Totally Leadless Dual-Device Implantation for Combined Spontaneous Ventricular Tachycardia Defibrillation and Pacemaker Function: A First Report.
    Ahmed FZ; Cunnington C; Motwani M; Zaidi AM
    Can J Cardiol; 2017 Aug; 33(8):1066.e5-1066.e7. PubMed ID: 28754393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Efficacy of Subcutaneous Cardioverter Defibrillator in Patients at High Risk of Sudden Cardiac Death　- Primary Japanese Experience.
    Sasaki S; Tomita H; Tsurugi T; Ishida Y; Shoji Y; Nishizaki K; Kinjo T; Endo T; Nishizaki F; Hanada K; Sasaki K; Horiuchi D; Kimura M; Higuma T; Okamatsu H; Tanaka Y; Koyama J; Okumura K
    Circ J; 2018 May; 82(6):1546-1551. PubMed ID: 29643282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous Implantable Cardioverter Defibrillator Lead Repositioning for Preventing Inappropriate Shocks Due to Myopotential Oversensing in a Post-Fulminant Myocarditis Patient.
    Sasaki T; Nakamura K; Naito S
    Int Heart J; 2019 Mar; 60(2):466-469. PubMed ID: 30745542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.
    Gold MR; El-Chami MF; Burke MC; Upadhyay GA; Niebauer MJ; Prutkin JM; Herre JM; Kutalek S; Dinerman JL; Knight BP; Leigh J; Lucas L; Carter N; Brisben AJ; Aasbo JD; Weiss R;
    J Am Coll Cardiol; 2023 Aug; 82(5):383-397. PubMed ID: 37495274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electromagnetic interference from left ventricular assist devices in patients with subcutaneous implantable cardioverter-defibrillators.
    Ishida Y; Payne JE; Field ME; Gold MR
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1195-1201. PubMed ID: 32128931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Third-generation subcutaneous implantable cardioverter defibrillator and intermuscular two-incision implantation technique in patients with Arrhythmogenic cardiomyopathy: 3-year follow-up.
    Migliore F; Pittorru R; De Lazzari M; Cipriani A; Bauce B; Marra MP; Giacomin E; Dall'Aglio PB; Accinelli S; Iliceto S; Corrado D
    Int J Cardiol; 2023 Jul; 382():33-39. PubMed ID: 37059308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.
    Kooiman KM; Knops RE; Olde Nordkamp L; Wilde AA; de Groot JR
    Heart Rhythm; 2014 Mar; 11(3):426-34. PubMed ID: 24321235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous implantable cardioverter defibrillators in patients with left ventricular assist devices: case report and comprehensive review.
    López-Gil M; Fontenla A; Delgado JF; Rodríguez-Muñoz D
    Eur Heart J Case Rep; 2019 Jun; 3(2):. PubMed ID: 31449611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
    Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personalized subcutaneous implantable cardioverter-defibrillator sensing vectors generated by mathematical rotation increase device eligibility whilst preserving device performance.
    Wiles BM; Roberts PR; Allavatam V; Acharyya A; Vemishetty N; ElRefai M; Wilson DG; Maharatna K; Chen H; Morgan JM
    Europace; 2022 Sep; 24(8):1267-1275. PubMed ID: 35022725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator.
    Gasperetti A; Schiavone M; Vogler J; Laredo M; Fastenrath F; Palmisano P; Ziacchi M; Angeletti A; Mitacchione G; Kaiser L; Compagnucci P; Breitenstein A; Arosio R; Vitali F; De Bonis S; Picarelli F; Casella M; Santini L; Pignalberi C; Lavalle C; Pisanò E; Ricciardi D; Calò L; Curnis A; Bertini M; Gulletta S; Dello Russo A; Badenco N; Tondo C; Kuschyk J; Tilz R; Forleo GB; Biffi M
    Heart Rhythm; 2022 Dec; 19(12):1958-1964. PubMed ID: 35781042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias.
    Raja J; Guice K; Oberoi M; Whitwell S; Asbeutah AA; Russell A; Khouzam RN
    Curr Probl Cardiol; 2022 Sep; 47(9):100927. PubMed ID: 34311985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous implantable cardioverter-defibrillator implantation in a patient with a left ventricular assist device already in place.
    Gupta A; Subzposh F; Hankins SR; Kutalek SP
    Tex Heart Inst J; 2015 Apr; 42(2):140-3. PubMed ID: 25873825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous Implantable Cardioverter-defibrillator Explantation-A Single Tertiary Center Experience.
    Pothineni NVK; Cherian T; Patel N; Smietana J; Frankel DS; Deo R; Epstein AE; Marchlinski FE; Schaller RD
    J Innov Card Rhythm Manag; 2022 Apr; 13(4):4947-4953. PubMed ID: 35474857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center.
    Grabowski M; Gawałko M; Michalak M; Cacko A; Kowara M; Kołodzińska A; Januszkiewicz Ł; Balsam P; Vitali Serdoz L; Winter J; Opolski G
    Cardiol J; 2019; 26(4):360-367. PubMed ID: 29611175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.